// App-Quantinova.ai

EP1001 : RELATIONSHIP BETWEEN CORNEAL EXAM FINDINGS, BEST-CORRECTED VISUAL ACUITY (BCVA), AND OCULAR SYMPTOMS IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) RECEIVING BELANTAMAB MAFODOTIN

Researchers

Presenter

  • Evangelos Terpos

Principal Investigators

  • Ashraf Badros

  • Rakesh Popat

  • Paula Rodriguez-Otero

  • Asim Farooq

  • Bennie Jeng

  • Simona Degli Esposti

  • Eric Lewis

  • Ira Gupta

  • Joanna Opalinska

  • Antonio Palumbo

  • Suzanne Trudel

Medical Centers

  • Rush University Medical Center, Chicago, Illinois, United States

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • University College London Hospitals NHS Trust, London, United Kingdom

  • Clínica Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA),Pamplona,Spain

  • GlaxoSmithKline,Zug,Switzerland

  • GlaxoSmithKline, Research Triangle Park, NC, United States.

  • GlaxoSmithKline, Upper Providence, PA, United States.

  • National and Kapodistrian University of Athens, Athens, Greece

  • University of Maryland School of Medicine, Baltimore, MD

  • NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London

Locations

  • United States

  • Canada

  • United Kingdom

  • Spain

  • Switzerland

  • Greece

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • N/A

Drug/Treatment

  • GSK2857916

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT03525678

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved